tiprankstipranks
Cybin: CYB003 data demonstres ‘breakthrough 12-month efficacy’ in MDD treatment
PremiumThe FlyCybin: CYB003 data demonstres ‘breakthrough 12-month efficacy’ in MDD treatment
1M ago
Rising High: Cannabis firms report quarterly earnings
Premium
The Fly
Rising High: Cannabis firms report quarterly earnings
1M ago
Cybin to Showcase Promising Depression Treatment Progress
Premium
Company Announcements
Cybin to Showcase Promising Depression Treatment Progress
1M ago
CYBN Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsCYBN Upcoming Earnings Report: What to Expect?
1M ago
Cybin to Highlight Innovations at Health Summit
Premium
Company Announcements
Cybin to Highlight Innovations at Health Summit
2M ago
Rising High: RIV Capital provides update on revenue, synergy realization
Premium
The Fly
Rising High: RIV Capital provides update on revenue, synergy realization
2M ago
Cybin Joins Prestigious Neuropsychiatry Summit
PremiumCompany AnnouncementsCybin Joins Prestigious Neuropsychiatry Summit
3M ago
Cybin price target lowered to $96 from $114 at Canaccord
Premium
The Fly
Cybin price target lowered to $96 from $114 at Canaccord
3M ago
Cybin Set to Launch Pivotal Phase 3 Depression Study
Premium
Company Announcements
Cybin Set to Launch Pivotal Phase 3 Depression Study
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100